The summaries are free for public
use. The Chronic Liver Disease
Foundation will continue to add and
archive summaries of articles deemed
relevant to CLDF by the Board of
Trustees and its Advisors.
Abstract Details
Role of chromosome 1q copy number variation in hepatocellular carcinoma
World J Hepatol. 2021 Jun 27;13(6):662-672. doi: 10.4254/wjh.v13.i6.662.
Author information
1Department of Microbiology and Immunology, Drexel University College of Medicine, Philadelphia, PA 19102, United States.
2Department of Microbiology and Immunology, Drexel University College of Medicine, Philadelphia, PA 19102, United States. pan29@drexel.edu.
Abstract
Chromosome 1q often has been observed to be amplified in hepatocellular carcinoma. This review summarizes literature reports of multiple genes that have been proposed as possible 1q amplification drivers. These largely fall within 1q21-1q23. In addition, publicly available copy number alteration data from The Cancer Genome Atlas project were used to identify additional candidate genes involved in carcinogenesis. The most frequent location for gene amplification was 1q22, consistent with the results of the literature search. The genes TPM3 and NUF2 were found to be candidates whose amplification and/or mRNA up-regulation was most highly associated with poorer hepatocellular carcinoma outcomes.